Literature DB >> 16691539

Recent advances in the treatment of colon cancer.

R Xu1, B Zhou, P C W Fung, X Li.   

Abstract

Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Although surgical resection is still the only treatment capable of curing colon cancer, adjuvant therapy continues to play an important role in preventing recurrence and metastasis. In recent years remarkable progress has been made in the treatment of colon cancer. This review discusses recent advances in adjuvant therapy for colon cancer, including chemotherapy, immunotherapy, antiangiogenic therapy and apoptosis induction. In the meantime, molecular therapy is also elucidated in the above methods. All these new advances will provide new promises for patients of colon cancer.

Entities:  

Mesh：

Year:  2006        PMID： 16691539     DOI： 10.14670/HH-21.867

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN： 0213-3911            Impact factor:   2.303


  13 in total

1.  Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer.

Authors:  Kazuhito Sasaki; Kazushige Kawai; Nelson H Tsuno; Eiji Sunami; Joji Kitayama
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

2.  Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.

Authors:  Yu-gang Wu; Guang-zhou Wu; Liang Wang; Yan-Yun Zhang; Zhong Li; De-Chun Li
Journal:  Med Oncol       Date:  2009-08-08       Impact factor: 3.064

Review 3.  The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.

Authors:  Miguel Munoz; Rafael Covenas; Francisco Esteban; Maximino Redondo
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

4.  Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.

Authors:  Kazuhito Sasaki; Nelson H Tsuno; Eiji Sunami; Giichiro Tsurita; Kazushige Kawai; Yurai Okaji; Takeshi Nishikawa; Yasutaka Shuno; Kumiko Hongo; Masaya Hiyoshi; Manabu Kaneko; Joji Kitayama; Koki Takahashi; Hirokazu Nagawa
Journal:  BMC Cancer       Date:  2010-07-15       Impact factor: 4.430

Review 5.  Insight to drug delivery aspects for colorectal cancer.

Authors:  Arvind Gulbake; Aviral Jain; Ashish Jain; Ankit Jain; Sanjay K Jain
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

6.  Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells.

Authors:  Hisanori Miki; Norihisa Uehara; Ayako Kimura; Tomo Sasaki; Takashi Yuri; Katsuhiko Yoshizawa; Airo Tsubura
Journal:  Int J Oncol       Date:  2012-01-03       Impact factor: 5.650

7.  Galectin-3-independent Down-regulation of GABABR1 due to Treatment with Korean Herbal Extract HAD-B Reduces Proliferation of Human Colon Cancer Cells.

Authors:  Kyung-Hee Kim; Yong-Kyun Kwon; Chong-Kwan Cho; Yeon-Weol Lee; So-Hyun Lee; Sang-Geun Jang; Byong-Chul Yoo; Hwa-Seong Yoo
Journal:  J Pharmacopuncture       Date:  2012-09

Review 8.  Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges.

Authors:  Jia-Cheng Tang; Yi-Li Feng; Xiao Liang; Xiu-Jun Cai
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

9.  Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.

Authors:  Bo Tang; Zhexu Li; Dingde Huang; Lei Zheng; Qianwei Li
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy.

Authors:  Deborah Rotoli; Manuel Morales; María Del Carmen Maeso; María Del Pino García; Araceli Morales; Julio Ávila; Pablo Martín-Vasallo
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.